Embargo Watch

Keeping an eye on how scientific information embargoes affect news coverage

Archive for March 2013

ASCO tweaks conference embargo policy

with one comment

ascoThe annual meeting of the American Society of Clinical Oncology (ASCO) is closely watched by reporters and Wall Street analysts alike, and that usually makes it good fodder for Embargo Watch. ASCO has changed its embargo policy regularly over the years, and this year is no exception.

According an email sent to reporters earlier this month: Read the rest of this entry »

Written by Ivan Oransky

March 18, 2013 at 2:05 pm

Posted in Uncategorized

PREVAILing (lack of) wisdom: Embargoes laid bare in a mess involving Boston Scientific (and a lot of others)

with 2 comments

acc logoBy now, Embargo Watch readers will probably have heard about Boston Scientific’s PREVAIL study of the Watchman stroke/clot prevention device, findings of which were scheduled to be presented at the American College of Cardiology (ACC) meeting on Sunday but weren’t, thanks to an embargo break by the company.
As theheart.org reported: Read the rest of this entry »

Written by Ivan Oransky

March 13, 2013 at 10:18 am

Posted in Uncategorized

New York Times breaks embargo on study of web searches and drug side effects

leave a comment »

jamiaThe New York Times broke the embargo earlier today on a Stanford and Microsoft Research study of whether tracking Internet searches can help researchers identify drug side effects.

Here’s the story from the Times, “Finding Hidden Side Effects, With Web Search Data,” which went live sometime before 5:30 p.m. Eastern. The study, in the Journal of the American Medical Informatics Association, was embargoed until 3:30 Pacific, or 6:30 Eastern.

And here’s the top of the press release: Read the rest of this entry »

Written by Ivan Oransky

March 6, 2013 at 6:54 pm

Posted in Uncategorized